FDA's REMS Stronghold: Industry Sees Need For Alternate Risk Management Plans Beyond Mandatory Programs

As Risk Evaluation and Mitigation Strategies become more and more commonplace, industry is starting to balk at the use of the mandatory programs for every risk management activity